Acadia Pharma Sells Voucher for Speedier FDA Drug Review for $150M
Acadia Pharmaceuticals committed a lot of money for rights to Daybue, which in the biotech’s hands became the first FDA-approved ...
Acadia Pharmaceuticals committed a lot of money for rights to Daybue, which in the biotech’s hands became the first FDA-approved ...
With Donald Trump now poised to become U.S. president for the second time in January, biotech and pharmaceutical leaders are ...
This is Part 5 of “Behind the Counter,” an in-depth video series demystifying the complex world of patents and drug ...
An Astellas Pharma drug designed to address a novel target has landed a highly anticipated FDA approval for a rare ...
Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company ...
An experimental GLP-1 obesity drug from Terns Pharmaceuticals led to a 5.5% reduction in body weight in a small study, ...
Former President Donald Trump and Vice President Kamala Harris have a rare point of agreement in their otherwise bitter and ...
The millions of people who regularly suffer from heartburn now have a new FDA-approved treatment option, a Phathom Pharmaceuticals drug ...
Insilico Medication("Insilico"), a clinical-stage generative synthetic intelligence (AI)-driven drug discovery firm, has efficiently delivered the second preclinical candidate compound (PCC) ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.